Physician-guided
Clinical review determines whether care is appropriate before treatment begins.
About Ayara
Modern peptide care with clinical restraint
Ayara Health brings physician-guided peptide access into a private telehealth model built for quality, clarity, and careful prescribing.
The mission
Ayara exists for people who want access to modern wellness therapies without losing medical judgment, privacy, or quality controls.
Peptides can feel confusing when they are presented like consumer products. Ayara treats them as clinical tools that require screening, education, and a prescribing decision.
The care model starts online, but the standard is medical: review the patient, determine eligibility, and only move forward when appropriate.
Standards before scale
Ayara is intentionally focused at launch, with two programs and one clinical workflow.
503A sourcing
Eligible prescriptions are sourced through U.S. 503A compounding pharmacies.
Independent testing
Products are independently third-party tested to support quality expectations.
HIPAA-compliant
Intake and communication are designed around privacy-minded telehealth workflows.
A telehealth model made for privacy
Ayara uses HIPAA-compliant workflows for intake and communication so patients can start with a focused clinical review from home.